Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.350
+0.010 (0.75%)
May 21, 2025, 10:57 AM - Market open
Longeveron Employees
Longeveron had 25 employees as of December 31, 2024. The number of employees increased by 1 or 4.17% compared to the previous year.
Employees
25
Change (1Y)
1
Growth (1Y)
4.17%
Revenue / Employee
$89,000
Profits / Employee
-$1,023,040
Market Cap
20.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LGVN News
- 1 day ago - Longeveron® to Attend BIO International Convention 2025 - GlobeNewsWire
- 9 days ago - Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient - GlobeNewsWire
- 11 days ago - Longeveron Inc. (LGVN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 19 days ago - Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewsWire
- 2 months ago - Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease - GlobeNewsWire
- 2 months ago - Longeveron® to Present at the 37th Annual Roth Conference - GlobeNewsWire
- 2 months ago - Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript - Seeking Alpha